Possible involvement of corticosterone and serotonin in antidepressant and antianxiety effects of chromium picolinate in chronic unpredictable mild stress induced depression and anxiety in rats

被引:40
作者
Dubey, Vivek Kumar [2 ]
Ansari, Faraha [2 ]
Vohora, Divya [2 ]
Khanam, Razia [1 ,2 ]
机构
[1] Gulf Med Univ, Dept Pharmacol, Ajman, U Arab Emirates
[2] Jamia Hamdard, Fac Pharm, Dept Pharmacol, New Delhi 110062, India
关键词
Chromium picolinate; Depression; Anxiety; Chronic unpredictable mild stress; Corticosterone; BRAIN; MODEL;
D O I
10.1016/j.jtemb.2014.06.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study, we investigated the effects of chromium picolinate (CrP) on behavioural and biochemical parameters in chronic unpredictable mild stress (CUMS) induced depression and anxiety in rats. The normal and stressed male Swiss albino rats were administered CrP (8 and 16 mu g/mL in drinking water), they received stressors for seven days (each day one stressor) and this cycle was repeated three times for 21 days. On 22nd day, behaviour assessments followed by biochemical estimations were conducted. The results showed that treatment of CrP produced significant antidepressant effect, which has been evidenced by decrease in immobility time in modified forced swimming test (FST) in chronic unpredictable mild stress (CUMS) induced depression in rats. In elevated plus maze (EPM), CrP (16 mu g/mL) showed significant reduction in time spent in open arm. CrP (8 mu g/mL and 16 mu g/mL) also showed significant decrease in number of entries in open arm that shows antianxiety effect of CrP in CUMS rats. It was also found that CrP (8 and 16 mu g/mL) significantly increased 5-HT concentration in the discrete regions of brain (cortex and cerebellum). On the other hand, the plasma corticosterone level was significantly decreased with CrP (16 mu g/mL). The results suggested that increase in the concentration of 5-HT and decrease in plasma corticosterone levels could be responsible for improvement in symptoms of depression and anxiety in CUMS induced depression and anxiety in rats. (C) 2014 Elsevier GmbH. All rights reserved.
引用
收藏
页码:222 / 226
页数:5
相关论文
共 26 条
[1]  
Anderson RA, 1998, J TRACE ELEM EXP MED, V11, P241, DOI 10.1002/(SICI)1520-670X(1998)11:2/3<241::AID-JTRA14>3.0.CO
[2]  
2-R
[3]  
Anderson RA., 1995, J ADV MED, V8, P37
[4]   Chromium treatment decreases the sensitivity of 5-HT2A receptors [J].
Attenburrow, MJ ;
Odontiadis, J ;
Murray, BJ ;
Cowen, PJ ;
Franklin, M .
PSYCHOPHARMACOLOGY, 2002, 159 (04) :432-436
[5]   Assessing antidepressant activity in rodents: recent developments and future needs [J].
Cryan, JF ;
Markou, A ;
Lucki, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (05) :238-245
[6]  
Cryang, 2005, NEUROSCI BIOBEHAV R, V29, P547
[7]   Effectiveness of chromium in atypical depression: A placebo-controlled trial [J].
Davidson, JRT ;
Abraham, K ;
Connor, KM ;
McLeod, MN .
BIOLOGICAL PSYCHIATRY, 2003, 53 (03) :261-264
[8]  
Franklin M, 2003, PHARMACOPSYCHIATRY, V36, P176
[9]   Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease [J].
Holmes, Andrew .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2008, 32 (07) :1293-1314
[10]   Etazolate, a phosphodiesterase 4 inhibitor reverses chronic unpredictable mild stress-induced depression-like behavior and brain oxidative damage [J].
Jindal, Ankur ;
Mahesh, Radhakrishnan ;
Bhatt, Shvetank .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 105 :63-70